| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.073 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |